Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05096026 · ClinicalTrials.gov registry record · NA

Effect of Electronic and Mail Outreach From Primary Care Physicians for COVID-19 Vaccination Among Elderly Patients

A NA study of Vaccination, sponsored by Kaiser Permanente.

Completed
Registry status
NA
Development phase
8,287
Enrollment target
1
Study location

NCT05096026 is a NA study of Vaccination that has completed, run by Kaiser Permanente. The registered enrollment target is 8,287 participants, below the 9,543-participant average among 12 other Vaccination trials with a reported enrollment target (13% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05096026, a NA study of Vaccination, has completed, sponsored by Kaiser Permanente.

COMPLETED
Registry status
NA
Development phase
8,287 participants
Enrollment target
1
Study location

Study Summary

This randomized controlled trial tested the effect of culturally tailored and standard electronic secure messages and mailings from patients' primary care physicians to encourage COVID-19 vaccination among adults aged 65 and older.

Conditions Studied

Interventions

  • BEHAVIORAL Standard PCP Outreach
  • BEHAVIORAL Culturally Tailored PCP Outreach

Study Locations (1)

California

  • Kaiser Permanente Northern California - Oakland

Trial Details

FieldValue
Enrollment Target 8,287 participants
Start Date 2021-03-29
Est. Completion 2021-08-31
Phase NA

Sponsor

Kaiser Permanente

294 total trials

What the Registry Record Tells You About NCT05096026

The ClinicalTrials.gov registry entry for NCT05096026 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8,287 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 9,543-participant average among 12 other Vaccination trials with a reported enrollment target (13% lower). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Vaccination appearing as the primary indexed condition, and to 2 interventions - of which Standard PCP Outreach is the first listed.

NCT05096026 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05096026 about?

NCT05096026 is a clinical study titled "Effect of Electronic and Mail Outreach From Primary Care Physicians for COVID-19 Vaccination Among Elderly Patients". This randomized controlled trial tested the effect of culturally tailored and standard electronic secure messages and mailings from patients' primary care physicians to encourage COVID-19 vaccination among adults aged 65 and older.

What is the current status of trial NCT05096026?

This trial is currently completed. It is a NA study. The enrollment target is 8,287 participants. The study started on 2021-03-29. Estimated completion is 2021-08-31.

What conditions does trial NCT05096026 study?

This clinical trial studies the following conditions: Vaccination.

What interventions are being tested in trial NCT05096026?

The interventions under investigation include: Standard PCP Outreach (BEHAVIORAL), Culturally Tailored PCP Outreach (BEHAVIORAL).

Who is sponsoring clinical trial NCT05096026?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05096026 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Vaccination

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.